Angiogenesis in ovarian follicular and luteal development

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 14, Issue 6, 2000, Pages 883-900

  Hazzard, Timothy M ^a   Stouffer, Richard L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Ageing, luteal phase defect; Angiogenesis; Angiopoietin; Fibroblast growth factor; Hypoxia; Luteinizing hormone; Ovarian hyperstimulation syndrome; Ovary; Polycystic ovarian syndrome; Ultrasound; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANGIOGENIN; ANGIOPOIETIN; ANGIOSTATIN; CHORIONIC GONADOTROPIN; ENDOSTATIN; ENDOTHELIAL CELL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FUMAGILLOL CHLOROACETYLCARBAMATE; GONADORELIN ANTAGONIST; GONADOTROPIN; LUTEINIZING HORMONE; PROMEGESTONE; TRILOSTANE; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR;

AGING; ANGIOGENESIS; BLOOD FLOWMETRY; CELL SPECIFICITY; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CORPUS LUTEUM; DIAGNOSTIC ACCURACY; DOSE RESPONSE; DRUG HALF LIFE; DRUG TARGETING; FEMALE INFERTILITY; HUMAN; HYPOXIA; LUTEAL INSUFFICIENCY; LUTEOLYSIS; NONHUMAN; OVARY DISEASE; OVARY FOLLICLE DEVELOPMENT; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASCULAR DISEASE;

EID: 0034493843     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.2000.0133     Document Type: Article

References (95)

1. The origin, development and degeneration of the blood vessels of the human ovary
2. Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary
3. Angiogenesis of the ovary
4. Cyclic changes of vasculature and vascular phenotypes in normal human ovaries
5. Temporal and topographic changes in DNA synthesis after induced follicular atresia
6. Cell signaling, permeability, and microvasculatory changes during antral follicle development in mammals
7. The changes in the vascular pattern of the ovary of the albino rat during the estrus cycle
8. The histological dating of the human corpus luteum of menstruation
9. Quantitative cell composition of human and bovine corpora lutea from various reproductive states
10. An immunohistochemical study of the vascularization of the human Graafian follicle
11. Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy
12. Mechanisms of luteolysis in domestic livestock
13. A quantitative study of changes in the human corpus luteum microvasculature during the menstrual cycle
14. Intraovarian regulation of luteolysis
15. Fumagillin analog in the treatment of Kaposi's sarcoma: A phase I AIDS clinical trial group study
16. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470
17. The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate
18. Injection of an angiogenesis inhibitor (TNP-470) into the periovulatory follicle causes luteal dysfunction in rhesus monkeys
19. Addressing tumor blood vessels
20. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles
21. Fibroblast growth factor receptor (FGFR)-1 and -2 in the ovine corpus luteum throughout the estrous cycle
22. The biology of vascular endothelial growth factor
23. The vascular endothelial growth factor family: Signalling for vascular development
24. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells
25. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary
26. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells
27. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary
28. Changes in expression of vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang-1) in the primate corpus luteum (CL) during the menstrual cycle
29. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis
30. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy
31. Immunoneutralization of angiogenic activity from ovine corpora lutea (CL) with antibodies against fibroblast growth factor (FGF)-2 and vascular endothelial growth factor (VEGF)
32. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
33. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor
34. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
35. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans
36. Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning
37. Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis
38. Signaling vascular morphogenesis and maintenance
39. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the periovulatory interval
40. Angiogenin is involved in morphological changes and angiogenesis in the ovary
41. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
42. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
43. Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction
44. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: Association with vascular endothelial growth factor levels and perifollicular blood flow characteristics
45. Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients
46. Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential
47. Angiogenesis in reproductive tissues
48. Expression of mRNA encoding basic fibroblast growth factor (bFGF) in bovine corpora lutea and cultured luteal cells
49. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent
50. Vascular endothelial growth factor (VEGF) production by human luteinized granulosa cells in vitro
51. Human follicle fluid vascular endothelial growth factor concentrations are correlated with luteinization in spontaneously developing follicles
52. Receptors for sex steroids in the primate corpus luteum. New insight into gonadotropin and steroid action
53. Steroid receptors and action in the primate follicle
54. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth
55. Progesterone induces vascular endothelial growth factor on retinal pigment epithelial cells in culture
56. Progestin regulation of vascular endothelial growth factor in human breast cancer cells
57. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response
58. Age-dependent impairment of angiogenesis
59. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-b levels
60. Age at menopause as a marker of reproductive ageing
61. Amenorrhea associated with bilateral polycystic ovaries
62. Polycystic ovaries - A common finding in normal women
63. Polycystic ovary syndrome - From gynaecological curiosity to multisystem endocrinopathy
64. Insulin-lowering therapeutic modalities for polycystic ovary syndrome
65. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries
66. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: Relevance to ovarian hyperstimulation syndrome and polycystic ovaries
67. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-1 in endometrial adenocarcinoma cells
68. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function
69. Luteal phase defects
70. Luteal phase defects and ectopic pregnancy
71. Color flow pulsed Doppler ultrasound in diagnosing luteal phase defect
72. Ovarian follicular dynamics: From basic science to clinical practice
73. Epigenetic influences on oocyte developmental competence: Perifollicular vascularity and intrafollicular oxygen
74. The pathophysiology of ovarian hyperstimulation syndrome - Views and ideas
75. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization
76. Ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy: Information about the general pathophysiology of OHSS
77. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome
78. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: A preliminary report
79. Vascular endothelial growth factor (VEGF) levels in serum and follicular fluid of patients undergoing in vitro fertilization
80. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome
81. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome
82. Transvaginal color flow Doppler in the assessment of ovarian and uterine blood flow in infertile women
83. Advanced ultrasound technology in the management of infertility
84. Power and colour Doppler ultrasonography for the evaluation of the vasculature of the human corpus luteum
85. Transvaginal pulsed Doppler ultrasound assessment of blood flow to the corpus luteum in IVF patients following embryo transfer
86. Preovulatory changes of blood flow in different regions of the human follicle
87. Evidence for the involvement of blood flow-related mechanisms in the ovulatory process of the rat
88. Ultrasound derived indices of follicular blood flow before HCG administration and the prediction of oocyte recovery and preimplantation embryo quality
89. Colour Doppler indices of follicular blood flow as predictors of pregnancy after in vitro fertilization and embryo transfer
90. Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment
91. Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: Association with changes in ovarian and uterine Doppler blood flow
92. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration